Westfield Capital Management CO LP Cerevel Therapeutics Holdings, Inc. Transaction History

Westfield Capital Management CO LP

  • $19.9 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
SELL
$20.27 - $42.44 $3.83 Million - $8.02 Million
-188,989 Reduced 19.39%
785,494 $33.3 Million
Q3 2023

Nov 13, 2023
BUY
$20.26 - $31.91 $8.08 Million - $12.7 Million
398,949 Added 69.32%
974,483 $21.3 Million
Q2 2023

Aug 11, 2023
BUY
$23.9 - $35.38 $13.8 Million - $20.4 Million
575,534 New
575,534 $18.3 Million

Others Institutions Holding CERE

# of Institutions
242
Shares Held
154M
Call Options Held
2.19M
Put Options Held
3.87M
View Full List

About Cerevel Therapeutics Holdings, Inc.

CERE Quotes by TradingView
  • Ticker CERE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 155,752,000
  • Description
  • Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...
More about CERE
Track This Portfolio

Track Westfield Capital Management CO LP Portfolio

Follow Westfield Capital Management CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Westfield Capital Management CO LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email